Eli Lilly and Company

-7.79%

More reviews (2)

Live  

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana. It was founded in 1876 by Colonel Eli Lilly, a pharmaceutical chemist, and is one of the largest pharmaceutical companies in the world.
The company's primary focus is on the development and production of prescription medications in various therapeutic areas, including neuroscience, oncology, immunology, and diabetes. Some of its most well-known products include the antidepressant Prozac, the erectile dysfunction drug Cialis, and the insulin Humalog.
Eli Lilly and Company also has a strong global presence, with operations in over 125 countries and sales in more than 120 countries. The company has a long history of innovation and has been responsible for groundbreaking medical discoveries, such as the first commercially available insulin in 1923.
In addition to its pharmaceutical business, Eli Lilly and Company also has a strong commitment to corporate responsibility and sustainability. The company has implemented various initiatives to reduce its environmental impact, improve access to healthcare, and support local communities.
Eli Lilly and Company employs over 35,000 people worldwide and has been consistently ranked as one of the top places to work by various publications. The company continues to invest in research and development to bring new and innovative treatments to patients around the world.

Eli Lilly and Company is a big company that makes medicine to help people feel better when they’re sick. Imagine if you had a cold or if someone had a more serious illness like diabetes or cancer; Eli Lilly creates special treatments and medicines that can help with those.
The way Eli Lilly makes money is by selling these medicines to hospitals, pharmacies, and doctors. When someone buys their medicine, Eli Lilly earns money. It’s like when you sell lemonade at a stand; if people buy your lemonade, you earn some money too!
Eli Lilly is successful because they invest a lot of time and money into research. They have scientists working to discover new medicines that can make people healthier. They also make sure that their products are very safe and effective before selling them. This is important because people trust them, and when people trust a company, they are more likely to buy its products.
Eli Lilly is likely to stay successful in the future for a few reasons. First, there are always new health challenges that people face, so there will be a need for new medicines. Second, they keep improving their existing medicines and finding new ways to help people. Lastly, as technology and science continue to get better, Eli Lilly will be able to create even more effective treatments, which will help more people and keep their business strong.

MS4gTG9uZy BoaXN0b3J5 OiBFbGkgTG lsbHkgYW5k IENvbXBhbn kgaGFzIGEg cmljaCBoaX N0b3J5IGRh dGluZyBiYW NrIHRvIGl0 cyBmb3VuZG luZyBpbiAx ODc2IGJ5IE NvbG9uZWwg RWxpIExpbG x5LiBPdmVy IHRoZSB5ZW FycywgdGhl IGNvbXBhbn kgaGFzIG92 ZXJjb21lIG 51bWVyb3Vz IGNoYWxsZW 5nZXMgYW5k IGFkYXB0ZW QgdG8gY2hh bmdpbmcgbW Fya2V0IGNv bmRpdGlvbn MsIG1ha2lu ZyBpdCBvbm Ugb2YgdGhl IG9sZGVzdC BhbmQgbW9z dCBlbmR1cm luZyBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMgaW 4gdGhlIHdv cmxkLjxicj 4yLiBEaXZl cnNlIHBvcn Rmb2xpbzog VGhlIGNvbX BhbnkgaGFz IGEgZGl2ZX JzZSBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMsIGVuY2 9tcGFzc2lu ZyBhIHdpZG UgcmFuZ2Ug b2YgdGhlcm FwZXV0aWMg YXJlYXMgc3 VjaCBhcyBu ZXVyb3NjaW VuY2UsIGVu ZG9jcmlub2 xvZ3ksIG9u Y29sb2d5LC BhbmQgaW1t dW5vbG9neS 4gVGhpcyBw cm92aWRlcy BhIHNvbGlk IGZvdW5kYX Rpb24gZm9y IHN1c3RhaW 5lZCBncm93 dGggYW5kIH Byb2ZpdGFi aWxpdHkuPG JyPjMuIFN0 cm9uZyBSJk QgZm9jdXM6 IEVsaSBMaW xseSBhbmQg Q29tcGFueS BpbnZlc3Rz IGhlYXZpbH kgaW4gcmVz ZWFyY2ggYW 5kIGRldmVs b3BtZW50LC Bjb25zdGFu dGx5IHNlZW tpbmcgbmV3 IHRyZWF0bW VudHMgYW5k IGN1cmVzIG ZvciBpbGxu ZXNzZXMuIF RoZSBjb21w YW55IHNwZW 5kcyBiaWxs aW9ucyBvZi Bkb2xsYXJz IGVhY2ggeW VhciBvbiBS JkQgYW5kIG hhcyBhIHJv YnVzdCBwaX BlbGluZSBv ZiBwb3Rlbn RpYWwgbmV3 IGRydWdzLj xicj40LiBH bG9iYWwgcm VhY2g6IFdp dGggb3Blcm F0aW9ucyBp biBvdmVyID EyNSBjb3Vu dHJpZXMsIE VsaSBMaWxs eSBhbmQgQ2 9tcGFueSBo YXMgYSB0cn VseSBnbG9i YWwgZm9vdH ByaW50LiBU aGlzIGFsbG 93cyB0aGUg Y29tcGFueS B0byByZWFj aCBhIHdpZG UgbWFya2V0 IGFuZCBtYW ludGFpbiBh IHN0cm9uZy BwcmVzZW5j ZSBpbiBib3 RoIGRldmVs b3BlZCBhbm QgZW1lcmdp bmcgbWFya2 V0cy48YnI+ NS4gQ29tbW l0bWVudCB0 byBpbm5vdm F0aW9uOiBU aGUgY29tcG FueSBoYXMg YSBzdHJvbm cgdHJhY2sg cmVjb3JkIG 9mIGlubm92 YXRpb24sIG JyaW5naW5n IGxpZmUtY2 hhbmdpbmcg dHJlYXRtZW 50cyB0byBt YXJrZXQuIE VsaSBMaWxs eSBhbmQgQ2 9tcGFueSBo YXMgYSBjdW x0dXJlIHRo YXQgZW5jb3 VyYWdlcyBy aXNrLXRha2 luZyBhbmQg Y3JlYXRpdm l0eSwgYW5k IGludmVzdH MgaW4gZW1l cmdpbmcgdG VjaG5vbG9n aWVzIHRvIG RyaXZlIGlu bm92YXRpb2 4uPGJyPjYu IFNvY2lhbC ByZXNwb25z aWJpbGl0eT ogRWxpIExp bGx5IGFuZC BDb21wYW55 IGhhcyBhIH N0cm9uZyBz ZW5zZSBvZi Bzb2NpYWwg cmVzcG9uc2 liaWxpdHkg YW5kIGlzIG NvbW1pdHRl ZCB0byBpbX Byb3Zpbmcg dGhlIHdlbG wtYmVpbmcg b2YgY29tbX VuaXRpZXMg d2hlcmUgaX Qgb3BlcmF0 ZXMuIFRoZS Bjb21wYW55 IGhhcyBpbm l0aWF0aXZl cyBmb2N1c2 VkIG9uIHBy b3ZpZGluZy BhY2Nlc3Mg dG8gbWVkaW NpbmVzIGZv ciB1bmRlcn NlcnZlZCBw b3B1bGF0aW 9ucywgcmVk dWNpbmcgaX RzIGVudmly b25tZW50YW wgZm9vdHBy aW50LCBhbm QgcHJvbW90 aW5nIGRpdm Vyc2UgYW5k IGluY2x1c2 l2ZSB3b3Jr cGxhY2VzLj xicj43LiBT dHJvbmcgZm luYW5jaWFs IHBlcmZvcm 1hbmNlOiBP dmVyIHRoZS B5ZWFycywg dGhlIGNvbX BhbnkgaGFz IG1haW50YW luZWQgYSBz b2xpZCBmaW 5hbmNpYWwg cGVyZm9ybW FuY2UgZGVz cGl0ZSBjaG FsbGVuZ2lu ZyBtYXJrZX QgY29uZGl0 aW9ucy4gRW xpIExpbGx5 IGFuZCBDb2 1wYW55IGhh cyBjb25zaX N0ZW50bHkg ZGVsaXZlcm VkIHN0cm9u ZyByZXZlbn VlIGdyb3d0 aCBhbmQgcH JvZml0YWJp bGl0eSwgbW FraW5nIGl0 IGEgZmluYW 5jaWFsbHkg c3RhYmxlIG FuZCByZWxp YWJsZSBjb2 1wYW55Ljxi cj44LiBFbX Bsb3llZS1j ZW50cmljIG N1bHR1cmU6 IFRoZSBjb2 1wYW55IHZh bHVlcyBpdH MgZW1wbG95 ZWVzIGFuZC BoYXMgYSBz dHJvbmcgZm 9jdXMgb24g Y3JlYXRpbm cgYSBwb3Np dGl2ZSB3b3 JrIGVudmly b25tZW50Li BFbGkgTGls bHkgYW5kIE NvbXBhbnkg b2ZmZXJzIG NvbXBldGl0 aXZlIGJlbm VmaXRzLCBv cHBvcnR1bm l0aWVzIGZv ciBjYXJlZX IgZ3Jvd3Ro LCBhbmQgYS BzdXBwb3J0 aXZlIGFuZC BpbmNsdXNp dmUgY3VsdH VyZSB0aGF0 IGZvc3Rlcn MgaW5ub3Zh dGlvbiBhbm QgY29sbGFi b3JhdGlvbi 4=

RWxpIExpbG x5IGFuZCBD b21wYW55IG lzIGEgZ2xv YmFsIHBoYX JtYWNldXRp Y2FsIGNvbX BhbnkgdGhh dCBmb2N1c2 VzIG9uIGRp c2NvdmVyaW 5nLCBkZXZl bG9waW5nLC BhbmQgbWFy a2V0aW5nIG lubm92YXRp dmUgbWVkaW NpbmVzIHRv IGltcHJvdm UgcGVvcGxl J3MgbGl2ZX MuIFRoZSBj b21wYW55J3 MgYnVzaW5l c3MgbW9kZW wgaXMgdG8g aW52ZXN0IG hlYXZpbHkg aW4gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50IHRv IGNyZWF0ZS BuZXcgZHJ1 Z3MgYW5kIH RyZWF0bWVu dHMgZm9yIG EgdmFyaWV0 eSBvZiBtZW RpY2FsIGNv bmRpdGlvbn MuIFRoaXMg aXMgZG9uZS B0aHJvdWdo IGEgY29tYm luYXRpb24g b2YgaW50ZX JuYWwgcmVz ZWFyY2ggZW Zmb3J0cywg cGFydG5lcn NoaXBzIHdp dGggb3RoZX IgY29tcGFu aWVzLCBhbm QgYWNxdWlz aXRpb25zIG 9mIHNtYWxs ZXIgYmlvdG VjaCBmaXJt cy48YnI+RW xpIExpbGx5 J3MgYnVzaW 5lc3MgbW9k ZWwgYWxzby BpbmNsdWRl cyBhIHN0cm 9uZyBmb2N1 cyBvbiBtYX JrZXRpbmcg YW5kIGJyYW 5kaW5nIHRv IGVmZmVjdG l2ZWx5IHBy b21vdGUgaX RzIHByb2R1 Y3RzIGFuZC BidWlsZCBi cmFuZCByZW NvZ25pdGlv bi4gVGhlIG NvbXBhbnkg aGVhdmlseS BpbnZlc3Rz IGluIHNhbG VzIGFuZCBt YXJrZXRpbm cgZWZmb3J0 cywgaW5jbH VkaW5nIGRp cmVjdC10by 1jb25zdW1l ciBhZHZlcn Rpc2luZyBh bmQgcGFydG 5lcnNoaXBz IHdpdGggaG VhbHRoY2Fy ZSBwcm92aW RlcnMuPGJy PkluIGFkZG l0aW9uIHRv IGRldmVsb3 BpbmcgYW5k IHNlbGxpbm cgcHJlc2Ny aXB0aW9uIG 1lZGljaW5l cywgRWxpIE xpbGx5IGFs c28gaGFzIG EgYnVzaW5l c3Mgc2VnbW VudCBkZWRp Y2F0ZWQgdG 8gYW5pbWFs IGhlYWx0aC Bwcm9kdWN0 cywgd2hpY2 ggaW5jbHVk ZXMgdmFjY2 luZXMgYW5k IHByZXNjcm lwdGlvbiBt ZWRpY2luZX MgZm9yIHBl dHMgYW5kIG xpdmVzdG9j ay48YnI+VG hlIGNvbXBh bnkncyBidX NpbmVzcyBt b2RlbCBhbH NvIGluY2x1 ZGVzIGEgc3 Ryb25nIGNv bW1pdG1lbn QgdG8gY29y cG9yYXRlIH NvY2lhbCBy ZXNwb25zaW JpbGl0eSwg d2l0aCBhIG ZvY3VzIG9u IHN1c3RhaW 5hYmxlIGFu ZCBldGhpY2 FsIHByYWN0 aWNlcywgY2 hhcml0YWJs ZSBnaXZpbm csIGFuZCBj b21tdW5pdH kgaW52b2x2 ZW1lbnQuPG JyPk92ZXJh bGwsIEVsaS BMaWxseSdz IGJ1c2luZX NzIG1vZGVs IGlzIGNlbn RlcmVkIG9u IHNjaWVudG lmaWMgaW5u b3ZhdGlvbi wgc3RyYXRl Z2ljIHBhcn RuZXJzaGlw cywgZWZmZW N0aXZlIG1h cmtldGluZy wgYW5kIGEg Y29tbWl0bW VudCB0byBz b2NpYWwgcm VzcG9uc2li aWxpdHksIG FsbCB3aXRo IHRoZSBnb2 FsIG9mIGlt cHJvdmluZy BwYXRpZW50 IGhlYWx0aC BhbmQgd2Vs bC1iZWluZy 4=

AI presents both opportunities and challenges for Eli Lilly and Company.
1. Substitution: AI technologies, particularly in drug discovery and development, could lead to new competitors emerging that utilize advanced algorithms to identify and develop alternatives to Eli Lilly’s products. These competitors may be able to bring drugs to market more efficiently and with potentially lower costs, which could threaten Eli Lilly’s market share in specific therapeutic areas.
2. Disintermediation: AI can enable new approaches to healthcare delivery and patient management, potentially reducing the need for traditional pharmaceutical distribution channels. For instance, direct-to-consumer models powered by AI advancements in diagnostics or personalized medicine may diminish the role of established pharmaceutical companies. This could lead to a reevaluation of Eli Lilly’s distribution strategies and partnerships.
3. Margin Pressure: As AI drives efficiencies in drug development and production processes, competitors utilizing these technologies may be able to produce drugs at lower costs. This could result in price pressures within the pharmaceutical industry, impacting Eli Lilly’s profit margins. Furthermore, if AI leads to the rapid introduction of generic versions of brand-name drugs, Eli Lilly’s revenue streams could be affected.
Overall, while AI poses some risks regarding substitution, disintermediation, and margin pressure, it also offers Eli Lilly the potential to enhance its own research capabilities, streamline operations, and improve patient outcomes. The company will need to strategically integrate AI technologies to mitigate these threats and leverage the advantages they offer.

The sensitivity of Eli Lilly and Company’s earnings, cash flow, and valuation to changes in interest rates can be attributed to several factors:
1. Earnings Sensitivity: Eli Lilly’s earnings can be impacted by interest rates through the cost of debt. If interest rates rise, the company’s borrowing costs may increase. This can affect net income, especially if the company relies on debt for expansion or operational funding. Conversely, lower interest rates can enhance profitability by reducing interest expenses.
2. Cash Flow Sensitivity: Interest rates can influence cash flow, particularly in terms of financing activities. As rates rise, cash outflows for interest payments may increase, affecting free cash flow. Additionally, if clients or partners are sensitive to interest rates—like healthcare providers that may face budget constraints—this could impact the company’s cash flow.
3. Valuation Sensitivity: The valuation of Eli Lilly is often assessed using discounted cash flow (DCF) models. Higher interest rates increase the discount rate applied to future cash flows, which can lower the present value of those cash flows and potentially decrease the company’s stock price. Lower rates would have the opposite effect, making the company’s future cash flows appear more valuable.
In summary, while Eli Lilly is fundamentally a pharmaceutical company with its own unique cash flow drivers, it is still susceptible to shifts in interest rates, particularly through financing costs and valuation implications.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvcV FuWXVOdTNz Nkg3S2NCeW ZWdUYud2Vi cCIgYWx0PS JFbGkgTGls bHkgYW5kIE NvbXBhbnki IHRpdGxlPS JFbGkgTGls bHkgYW5kIE NvbXBhbnki ICBjbGFzcz 0iaW1nLWZs dWlkIiBoZW lnaHQ9OTAg d2lkdGg9OT AgbG9hZGlu Zz0nbGF6eS cgc3R5bGU9 J2JvcmRlci 1yYWRpdXM6 IDZweDsnPg oKICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdmbGV4 OiAxOyB0ZX h0LWFsaWdu OiBjZW50ZX I7IG1hcmdp bi1sZWZ0Oi A1cHg7Jz4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPHAgc3R5 bGU9J2Zvbn Qtc2l6ZTog MjZweDsgY2 9sb3I6ICMz MzM7IG1hcm dpbi1ib3R0 b206IDE1cH g7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIPCfk4gg V2FudCB0by ByZWFkIG1v cmUgYWJvdX QgRWxpIExp bGx5IGFuZC BDb21wYW55 PwogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdpbm RleC5waHA/ cGFnZT1zaW dudXAnIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJhY2 tncm91bmQt Y29sb3I6IC MwMDdCRkY7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBj b2xvcjogI2 ZmZjsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH ggMjBweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJv cmRlci1yYW RpdXM6IDVw eDsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHRleHQtZG Vjb3JhdGlv bjogbm9uZT sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG ZvbnQtd2Vp Z2h0OiBib2 xkOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgbWFyZ2lu LXJpZ2h0Oi AxMHB4Owog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdHJh bnNpdGlvbj ogYmFja2dy b3VuZC1jb2 xvciAwLjNz IGVhc2U7Jw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgb2 5tb3VzZW92 ZXI9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA1Nm IzIicKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIG9ubW91 c2VvdXQ9J3 RoaXMuc3R5 bGUuYmFja2 dyb3VuZENv bG9yPSIjMD A3QkZGIic+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG ZvciBmcmVl CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvYT4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxzcGFu IHN0eWxlPS dtYXJnaW46 IDAgOHB4Oy Bjb2xvcjog IzU1NTsnPm 9yPC9zcGFu PgoKICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naW 5kZXgucGhw P3BhZ2U9bG 9naW4nIHN0 eWxlPScKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGNvbG 9yOiAjMDA3 QkZGOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdGV4dC 1kZWNvcmF0 aW9uOiB1bm RlcmxpbmU7 CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBm b250LXdlaW dodDogNTAw Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICBsb2cgaW 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg oKCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxwIH N0eWxlPSdt YXJnaW4tdG 9wOiAxNXB4 OyBmb250LX NpemU6IDEz cHg7IGZvbn Qtd2VpZ2h0 OiBib2xkOy Bjb2xvcjog I2QzMmYyZj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag4pyN77iP IFNpZ24gdX AgdG8gZ2V0 IDxpPiJUaG UgQ2hlY2ts aXN0IFZhbH VlIEludmVz dG9yIOKAlC BBIFNtYXJ0 ZXIgV2F5IH RvIFBpY2sg U3RvY2tzIj wvaT4gZm9y IGZyZWUKIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9wPgoKIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxMnB4OyBm b250LXNpem U6IDEzcHg7 IGNvbG9yOi AjNDQ0Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBT aWduIHVwIG 5vdyBhbmQg Z2V0IG91ci BmcmVlIGVC b29rIAogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPGI+VG hlIENoZWNr bGlzdCBWYW x1ZSBJbnZl c3RvciDigJ QgQSBTbWFy dGVyIFdheS B0byBQaWNr IFN0b2Nrcz wvYj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC 0tPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDE2 cHg7IGZvbn Qtc2l6ZTog MTRweDsgY2 9sb3I6ICM0 NDQ7IGZvbn QtZmFtaWx5 OiAtYXBwbG Utc3lzdGVt LCBCbGlua0 1hY1N5c3Rl bUZvbnQsIF NlZ29lIFVJ LCBSb2JvdG 8sIEhlbHZl dGljYSBOZX VlLCBzYW5z LXNlcmlmOy BsaW5lLWhl aWdodDogMS 42Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBIYXZl IHlvdSBoZW FyZCBhYm91 dCBvdXIgc2 hvcnQgPHN0 cm9uZyBzdH lsZT0nZm9u dC13ZWlnaH Q6IDYwMDsn PkRhaWx5IF ZpZGVvIE5l d3NsZXR0ZX I8L3N0cm9u Zz4/CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdodHRw czovL3d3dy 5pbnNpZ2h0 ZnVsdmFsdW UuY29tL25l d3NsZXR0ZX IucGhwJyB0 YXJnZXQ9J1 9ibGFuaycg c3R5bGU9J2 NvbG9yOiAj MDA3QkZGOy B0ZXh0LWRl Y29yYXRpb2 46IG5vbmU7 IGZvbnQtd2 VpZ2h0OiA1 MDA7IG1hcm dpbi1sZWZ0 OiA2cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBGaW5k IG91dCBtb3 JlCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8L2E+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg ICAgICAgIC AtLT4KICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICA8 L2Rpdj4KIC AgICAgICAg ICAgCiAgIC AgICAgCiAg ICAgICAgPH NwYW4gY2xh c3M9J2JsdX JyZWQtdGV4 dCc+CiAgIC AgICAgICAg IE1TNGdSV3 hwSUUgeHBi R3g1SUdGdS BaQ0JEYjIx d1lXIDU1SU dseklHRnUg SUVGdFpYSn BZMiBGdUlH MTFiSFJwIG JtRjBhVzl1 WVcgd2djR2 hoY20xaCBZ MlYxZEdsal lXIHdnWTI5 dGNHRnUgZV NCb1pXRmtj WCBWaGNuUm xjbVZrIElH bHVJRWx1Wk cgbGhibUZ3 YjJ4cCBjeX dnU1c1a2FX IEZ1WVM0OF luSSsgTWk0 Z1ZHaGxJRy BOdmJYQmhi bmtnIGQyRn pJR1p2ZFcg NWtaV1FnYV c0ZyBNVGcz TmlCaWVTIE JEYjJ4dmJt VnMgSUVWc2 FTQk1hVyB4 c2VTd2dZU0 J3IGFHRnli V0ZqWlggVj BhV05oYkNC aiBhR1Z0YV hOMExDIEJo Ym1RZ2FYTW cgYzNScGJH d2dibSBGdF pXUWdZV1ow IFpYSWdhR2 x0TGogeGlj ajR6TGlCSi BiaUJwZEhN Z1pXIEZ5Yk hrZ2VXVmgg Y25Nc0lFVn NhUyBCTWFX eHNlU0JoIG JtUWdRMjl0 Y0cgRnVlU0 J3Y21sdCBZ WEpwYkhrZ2 NIIEp2WkhW alpXUWcgYl dWa2FXTnBi bSBWeklHUm xjbWwyIFpX UWdabkp2Yl MgQmhibWx0 WVd3ZyBiM0 puWVc1ekxD IEJ6ZFdOb0 lHRnogSUds dWMzVnNhVy A0Z1puSnZi U0IwIGFHVW djR0Z1WTMg SmxZWE1nYj JZZyBZMjkz Y3lCaGJtIF FnY0dsbmN5 NDggWW5JK0 5DNGdWRyA5 a1lYa3NJRV ZzIGFTQk1h V3hzZVMgQm hibVFnUTI5 dCBjR0Z1ZV NCcGN5IEJ2 Ym1VZ2IyWW cgZEdobElH eGhjbSBkbG MzUWdZVzVr IElHMXZjM1 FnYzMgVmpZ MlZ6YzJaMS BiQ0J3YUdG eWJXIEZqWl hWMGFXTmgg YkNCamIyMX dZVyA1cFpY TWdhVzRnIG RHaGxJSGR2 Y20geGtMaU JKZENCcCBj eUJsYzNScG JXIEYwWldR Z2RHOGcgWW 1VZ2QyOXlk RyBnZ2IzWm xjaUFrIE1U VXdJR0pwYk cgeHBiMjR1 UEdKeSBQal V1SUZSb1pT IEJqYjIxd1 lXNTUgSUdo aGN5QmhJSC BOMGNtOXVa eUJtIGIyTj FjeUJ2Ymkg QnlaWE5sWV hKaiBhQ0Jo Ym1RZ1pHIF YyWld4dmNH MWwgYm5RZ2 IyWWdibSBW M0lIUnlaV0 YwIGJXVnVk SE1nWm0gOX lJSFpoY21s diBkWE1nWk dselpXIEZ6 WlhNc0lIZH AgZEdnZ2Iz WmxjaSBBM0 xEQXdNQ0J6 IFkybGxibl JwYzMgUnpJ R0Z1WkNCeS BaWE5sWVhK amFHIFZ5Y3 lCbGJYQnMg YjNsbFpDQm 5iRyA5aVlX eHNlUzQ4IF luSStOaTRn UlcgeHBJRX hwYkd4NSBJ R0Z1WkNCRG IyIDF3WVc1 NUlHbHogSU cxdmMzUWdk MiBWc2JDMX JibTkzIGJp Qm1iM0lnYV ggUnpJR1Js ZG1WcyBiM0 J0Wlc1MElH IEZ1WkNCd2 NtOWsgZFdO MGFXOXVJRy A5bUlGQnli M3BoIFl5d2 dZU0J3YjMg QjFiR0Z5SU dGdSBkR2xr WlhCeVpYIE 56WVc1MElH MWwgWkdsal lYUnBiMiA0 c0lHbHVJSF JvIFpTQnNZ WFJsSUQgRT VPREJ6TGp4 aSBjajQzTG lCVWFHIFVn WTI5dGNHRn UgZVNCb1lY TWdZVyB4em J5QnRZV1Js IElITnBaMj VwWm0gbGpZ VzUwSUdOdi BiblJ5YVdK MWRHIGx2Ym 5NZ2FXNGcg ZEdobElHWn BaVyB4a2N5 QnZaaUJrIG FXRmlaWFJs Y3kgd2dZMk Z1WTJWeSBM Q0JoYm1RZ2 JtIFYxY205 elkybGwgYm 1ObElIUnla VyBGMGJXVn VkSE11IFBH SnlQamd1SU UgVnNhU0JN YVd4cyBlU0 JoYm1RZ1Ey IDl0Y0dGdW VTQm8gWVhN Z1lTQndjbS BWelpXNWpa U0JwIGJpQn ZkbVZ5SUQg RXlOU0JqYj NWdSBkSEpw WlhNZ1lXID VrSUhObGJH eHogSUhCeW IyUjFZMyBS eklHbHVJR0 Z3IGNISnZl R2x0WVggUm xiSGtnTVRJ dyBJR052ZF c1MGNtIGxs Y3lCM2IzSn MgWkhkcFpH VXVQRyBKeV Bqa3VJRlJv IFpTQmpiMj F3WVcgNTVJ R2hoY3lCaC BJR3h2Ym1j Z2FHIGx6ZE c5eWVTQnYg WmlCd2FHbH NZVyA1MGFI SnZjSGtzIE lIZHBkR2dn WVMgQm1iMk 4xY3lCdiBi aUJwYlhCeW IzIFpwYm1j Z1oyeHYgWW 1Gc0lHaGxZ VyB4MGFDQm hibVFnIGMz VndjRzl5ZE cgbHVaeUJq YjIxdCBkVz VwZEdsbGN5 IDRnU1hRZ2 FHRnogSUdS dmJtRjBaVy BRZ2IzWmxj aUFrIE56QX dJRzFwYkcg eHBiMjRnYV c0ZyBjSEp2 WkhWamRIIE 1nWVc1a0lH TmggYzJnZ2 RHOGdkbSBG eWFXOTFjeU J2IGNtZGhi bWw2WVggUn BiMjV6SUdG dSBaQ0JwYm 1sMGFXIEYw YVhabGN5Qn ogYVc1alpT QXlNRCBBME xqeGljajR4 IE1DNGdTVz RnTWogQXlN Q3dnUld4cC BJRXhwYkd4 NUlHIEZ1Wk NCRGIyMXcg WVc1NUlIZG hjeSBCcGJu WnZiSFpsIF pDQnBiaUIw YUcgVWdaR1 YyWld4diBj RzFsYm5RZ2 IyIFlnWVc0 Z1lXNTAgYV dKdlpIa2dk SCBKbFlYUn RaVzUwIElH WnZjaUJEVD EgWkpSQzB4 T1N3ZyBkMm hwWTJnZ2Qy IEZ6SUdkeV lXNTAgWldR Z1pXMWxjbS BkbGJtTjVJ SFZ6IFpTQm hkWFJvYjMg SnBlbUYwYV c5dSBJR0o1 SUhSb1pTIE JWTGxNdUlF WnYgYjJRZ1 lXNWtJRSBS eWRXY2dRV1 J0IGFXNXBj M1J5WVggUn BiMjR1CiAg ICAgICAgPC 9zcGFuPgog ICAgICAgIA ogICAgICAg IA==